Product Overview
[Drug Name]
Generic Name: Nifedipine Controlled-Release Tablets
Trade Name: Naite Nifedipine Controlled-Release Tablets 30mg*10 Tablets
Pinyin Code: NaiTe XiaoBenDiPingKongShiPian 30mg*10 Tablets
[Main Ingredient]
The main ingredient of this product is nifedipine.
[Properties]
Nifedipine controlled-release tablets are film-coated tablets. After removing the coating, the core tablets are yellow and red bilayer tablets.
[Indications/Main Functions]
1. Hypertension. 2. Coronary Heart Disease: Chronic Stable Angina (Exertional Angina).
[Drug Interactions]
Contraindicated in patients with known hypersensitivity to nifedipine. Contraindicated in cardiogenic shock. Due to enzyme induction, nifedipine cannot achieve effective blood concentrations when used with rifampicin. Therefore, it should not be used in combination with rifampicin. Contraindicated in pregnant and lactating women.
[Specifications]
30mg*10 tablets
[Dosage and Administration]
Treatment should be tailored to individual needs whenever possible. A different basal dose may be administered based on the patient's clinical condition. Patients with liver impairment should be carefully monitored, and the dose should be reduced in severe cases. The recommended dosage for adults is one 30mg tablet once daily, unless specifically directed by a physician. Treatment duration: The duration of administration should be determined by the physician. Dosage: Nifedipine controlled-release tablets are usually swallowed whole with a small amount of liquid, regardless of mealtimes. Do not chew or break the tablets before taking.
[Contraindications]
Contraindicated in patients with a known hypersensitivity to nifedipine. Contraindicated in cardiogenic shock. Due to enzyme induction, nifedipine does not achieve effective blood concentrations when used with rifampicin. Therefore, concomitant use with rifampicin is contraindicated. Contraindicated in pregnant and lactating women.
